
Maris R. Kessel
Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )
| Most Active Art Unit | 1759 |
| Art Unit(s) | 1795, 1759, 1758, 1699 |
| Total Applications | 485 |
| Issued Applications | 239 |
| Pending Applications | 11 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18158785
[patent_doc_number] => 20230025377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUS
[patent_app_type] => utility
[patent_app_number] => 17/797643
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/797643 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUS | Feb 11, 2021 | Abandoned |
Array
(
[id] => 16873955
[patent_doc_number] => 20210167422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => LIQUID ELECTROLYTE FOR BATTERY
[patent_app_type] => utility
[patent_app_number] => 17/172760
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172760 | Liquid electrolyte for battery | Feb 9, 2021 | Issued |
Array
(
[id] => 16870048
[patent_doc_number] => 20210163515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => BENFOTIAMINE DERIVATIVES IN THE TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/173059
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173059 | Benfotiamine derivatives in the treatment of alzheimer's disease | Feb 9, 2021 | Issued |
Array
(
[id] => 16869990
[patent_doc_number] => 20210163457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/172861
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172861 | CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF | Feb 9, 2021 | Abandoned |
Array
(
[id] => 19043570
[patent_doc_number] => 11932654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Nimbolide analogs as anti-cancer agents and preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/171276
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7147
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171276 | Nimbolide analogs as anti-cancer agents and preparation thereof | Feb 8, 2021 | Issued |
Array
(
[id] => 18349782
[patent_doc_number] => 20230137893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS
[patent_app_type] => utility
[patent_app_number] => 17/760143
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760143 | PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS | Feb 4, 2021 | Pending |
Array
(
[id] => 18329191
[patent_doc_number] => 11634419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Dimethyl amino azetidine amides as JAK inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/248717
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24194
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248717 | Dimethyl amino azetidine amides as JAK inhibitors | Feb 3, 2021 | Issued |
Array
(
[id] => 16854883
[patent_doc_number] => 20210155628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Heterocyclic Compounds as RET Kinase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/165151
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165151 | Heterocyclic compounds as RET kinase inhibitors | Feb 1, 2021 | Issued |
Array
(
[id] => 18241117
[patent_doc_number] => 20230073428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL HYPERTENSION WITH SELEXIPAG
[patent_app_type] => utility
[patent_app_number] => 17/759467
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759467 | METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL HYPERTENSION WITH SELEXIPAG | Feb 1, 2021 | Abandoned |
Array
(
[id] => 16839442
[patent_doc_number] => 20210147454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COT MODULATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/162754
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162754 | Cot modulators and methods of use thereof | Jan 28, 2021 | Issued |
Array
(
[id] => 17050602
[patent_doc_number] => 20210260036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/162129
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162129 | METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY | Jan 28, 2021 | Abandoned |
Array
(
[id] => 20505875
[patent_doc_number] => 12540142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-03
[patent_title] => Method for evaluating quality of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl)hex-4-inoic acid
[patent_app_type] => utility
[patent_app_number] => 17/759305
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 383
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759305 | METHOD FOR EVALUATING QUALITY OF (3S)-3-(4-(3-(1,4-DIOXASPIRO[4,5]DEC-7-EN-8-YL)BENZYLOXY)PHENYL)HEX-4-INOIC ACID | Jan 28, 2021 | Issued |
Array
(
[id] => 18320275
[patent_doc_number] => 20230118403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => PROPYLENE OXIDE PRODUCTION APPARATUS AND PROPYLENE OXIDE PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/909596
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909596
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909596 | PROPYLENE OXIDE PRODUCTION APPARATUS AND PROPYLENE OXIDE PRODUCTION METHOD | Jan 27, 2021 | Pending |
Array
(
[id] => 17761467
[patent_doc_number] => 20220235079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Crystalline Forms of Tenofovir Alafenamide
[patent_app_type] => utility
[patent_app_number] => 17/159238
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159238 | Crystalline forms of Tenofovir alafenamide | Jan 26, 2021 | Issued |
Array
(
[id] => 16824156
[patent_doc_number] => 20210139449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => CONVERSION OF CANNABIDIOL OR DELTA-9 TETRAHYDROCANNABINOLIC ACID TO DELTA-9 TETRAHYDROCANNABINOL AND DELTA-8 TETRAHYDROCANNABINOL IN NONTOXIC HETEROGENEOUS MIXTURES
[patent_app_type] => utility
[patent_app_number] => 17/157078
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157078 | CONVERSION OF CANNABIDIOL OR DELTA-9 TETRAHYDROCANNABINOLIC ACID TO DELTA-9 TETRAHYDROCANNABINOL AND DELTA-8 TETRAHYDROCANNABINOL IN NONTOXIC HETEROGENEOUS MIXTURES | Jan 24, 2021 | Abandoned |
Array
(
[id] => 16839376
[patent_doc_number] => 20210147388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/155244
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 559
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155244 | Imidazolyl kinase inhibitors and uses thereof | Jan 21, 2021 | Issued |
Array
(
[id] => 19904114
[patent_doc_number] => 12281110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Processes for preparing an FGFR inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/155726
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 8619
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155726 | Processes for preparing an FGFR inhibitor | Jan 21, 2021 | Issued |
Array
(
[id] => 18308010
[patent_doc_number] => 20230111910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/794390
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794390 | PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Jan 20, 2021 | Pending |
Array
(
[id] => 18270225
[patent_doc_number] => 20230091467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => FUSED RING SUBSTITUTED AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/437192
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437192 | Fused ring substituted aromatic compound and preparation method therefor, herbicidal composition, and use thereof | Jan 11, 2021 | Issued |
Array
(
[id] => 16945900
[patent_doc_number] => 20210204591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => TERPENES AND THC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/248047
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248047 | TERPENES AND THC COMPOSITIONS AND METHODS | Jan 5, 2021 | Pending |